Laboratory of Molecular Physiology, National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism, 5625 Fishers Lane, Room TS-11, MSC 9411, Bethesda, MD 20892, USA.
Mol Pharmacol. 2013 Jan;83(1):267-82. doi: 10.1124/mol.112.081182. Epub 2012 Oct 25.
Recent studies propose that N-arachidonyl glycine (NAGly), a carboxylic analogue of anandamide, is an endogenous ligand of the Gα(i/o) protein-coupled receptor 18 (GPR18). However, a high-throughput β-arrestin-based screen failed to detect activation of GPR18 by NAGly (Yin et al., 2009; JBC, 18:12328). To address this inconsistency, this study investigated GPR18 coupling in a native neuronal system with endogenous signaling pathways and effectors. GPR18 was heterologously expressed in rat sympathetic neurons, and the modulation of N-type (Ca(v)2.2) calcium channels was examined. Proper expression and trafficking of receptor were confirmed by the "rim-like" fluorescence of fluorescently tagged receptor and the positive staining of external hemagglutinin-tagged GPR18-expressing cells. Application of NAGly on GPR18-expressing neurons did not inhibit calcium currents but instead potentiated currents in a voltage-dependent manner, similar to what has previously been reported (Guo et al., 2008; J Neurophysiol, 100:1147). Other proposed agonists of GPR18, including anandamide and abnormal cannabidiol, also failed to induce inhibition of calcium currents. Mutants of GPR18, designed to constitutively activate receptors, did not tonically inhibit calcium currents, indicating a lack of GPR18 activation or coupling to endogenous G proteins. Other downstream effectors of Gα(i/o)-coupled receptors, G protein-coupled inwardly rectifying potassium channels and adenylate cyclase, were not modulated by GPR18 signaling. Furthermore, GPR18 did not couple to other G proteins tested: Gα(s), Gα(z), and Gα(15). These results suggest NAGly is not an agonist for GPR18 or that GPR18 signaling involves noncanonical pathways not examined in these studies.
最近的研究表明,N-花生四烯酰甘氨酸(NAGly)是一种内源性的 Gα(i/o)蛋白偶联受体 18(GPR18)的羧酸类似物,是其配体。然而,一种基于高内涵β-抑制蛋白的筛选未能检测到 NAGly 对 GPR18 的激活(Yin 等人,2009;JBC,18:12328)。为了解决这一不一致性,本研究在具有内源性信号通路和效应器的天然神经元系统中研究了 GPR18 的偶联。GPR18 在大鼠交感神经元中异源表达,并检测 N 型(Ca(v)2.2)钙通道的调制。通过荧光标记受体的“边缘状”荧光和对外源血凝素标记的 GPR18 表达细胞的阳性染色,证实了受体的正确表达和转运。在表达 GPR18 的神经元上应用 NAGly 不会抑制钙电流,而是以电压依赖性的方式增强电流,这与之前的报道相似(Guo 等人,2008;J Neurophysiol,100:1147)。其他被认为是 GPR18 激动剂的物质,包括内源性大麻素和异常大麻素,也未能诱导钙电流抑制。设计用于组成性激活受体的 GPR18 突变体不能持续抑制钙电流,表明缺乏 GPR18 激活或与内源性 G 蛋白偶联。Gα(i/o) 偶联受体的其他下游效应器,G 蛋白偶联内向整流钾通道和腺苷酸环化酶,不受 GPR18 信号的调节。此外,GPR18 也不与其他在这些研究中测试的 G 蛋白偶联:Gα(s)、Gα(z)和 Gα(15)。这些结果表明,NAGly 不是 GPR18 的激动剂,或者 GPR18 信号涉及本研究中未检查的非典型途径。